欧洲、美国与澳大利亚临床实践中动脉瘤性蛛网膜下腔出血夹闭与栓塞的结局
该非随机对照研究基于2007-2013年22家三级医院的7658例aSAH行政数据,比较栓塞与夹闭的14天病死率,并在2个欧洲中心1501例临床数据中进一步探索。行政数据中调整后栓塞较夹闭14天病死率OR为1.32(95%CI 1.10-1.58);临床数据中14天病死率OR为1.7(95%CI 1.1-2.7),90天病死率OR为1.28(95%CI 0.91-1.82),90天功能不良结局OR为0.78(95%CI 0.6-1.01)。作者结论认为临床实践中栓塞与14天病死率较高相关,90天结局不优于夹闭。
要点
- 行政数据中粗14天病死率夹闭6.4%(95%CI 5.6%-7.2%),栓塞8.2%(95%CI 7.4%-9.1%)。
- 临床数据中粗14天病死率夹闭5.7%(95%CI 4.2%-7.8%),栓塞9.0%(95%CI 7.3%-11.2%)。
- 作者结论认为两种方案均需在aSAH患者中考虑,需进一步研究解释与RCT的差异。
核心结论
- 临床实践中,aSAH后栓塞与较夹闭更高的14天病死率相关,且90天结局不优于夹闭。
- 两种方案均需在aSAH患者中考虑。
- 需进一步研究探讨当前数据与随机临床试验结果差异的原因。
研究设计与样本
- 研究为对照、非随机研究,比较破裂颅内动脉瘤血管内栓塞与神经外科夹闭的结局。
- 行政数据集纳入7658例aSAH患者,来自欧洲、美国、澳大利亚的22家三级医院,时间2007-2013年。
- 因结果与随机试验矛盾,进一步在2个欧洲中心1501例患者的临床数据集中探索,时间2006-2016年。
主要发现
- 行政数据集中粗14天病死率夹闭6.4%(95%CI 5.6%-7.2%),栓塞8.2%(95%CI 7.4%-9.1%)。
- 行政数据集调整年龄、性别、合并症/严重程度后,栓塞较夹闭14天病死率OR为1.32(95%CI 1.10-1.58)。
- 临床数据集中粗14天病死率夹闭5.7%(95%CI 4.2%-7.8%),栓塞9.0%(95%CI 7.3%-11.2%)。
- 临床数据集多变量logistic回归中,栓塞较夹闭14天病死率OR为1.7(95%CI 1.1-2.7),90天病死率OR为1.28(95%CI 0.91-1.82),90天功能不良结局OR为0.78(95%CI 0.6-1.01)。
临床怎么用
- 作者结论认为两种方案均需在aSAH患者中考虑。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Within randomized clinical trials (RCTs), coiling of the ruptured aneurysm to prevent rebleeding results in better outcomes than clipping in patients with aneurysmal subarachnoid hemorrhage (aSAH). OBJECTIVE: To study the association of coiling and clipping with outcome after aSAH in daily clinical practice. METHODS: In this controlled, nonrandomized study, we compared outcomes after endovascular coiling and neurosurgical clipping of ruptured intracranial aneurysms in an administrative dataset of 7658 aSAH patients (22 tertiary care hospitals from Europe, USA, Australia; 2007-2013). Because the results contradicted those of the randomized trials, findings were further explored in a large clinical dataset from 2 European centers (2006-2016) of 1501 patients. RESULTS: In the administrative dataset, the crude 14-d case-fatality rate was 6.4% (95% confidence interval [CI] 5.6%-7.2%) after clipping and 8.2% (95% CI 7.4%-9.1%) after coiling. After adjustment for age, sex, and comorbidity/severity, the odds ratio (OR) for 14-d case-fatality after coiling compared to clipping was 1.32 (95% CI 1.10-1.58). In the clinical dataset crude 14-d case fatality rate was 5.7% (95% CI 4.2%-7.8%) for clipping and 9.0% (95% CI 7.3%-11.2%) for coiling. In multivariable logistic regression analysis, the OR for 14-d case-fatality after coiling compared to clipping was 1.7 (95% CI 1.1-2.7), for 90-d case-fatality 1.28 (95% CI 0.91-1.82) and for 90-d poor functional outcome 0.78 (95% CI 0.6-1.01). CONCLUSION: In clinical practice, coiling after aSAH is associated with higher 14-d case-fatality than clipping and nonsuperior outcomes at 90 d. Both options need to be considered in aSAH patients. Further studies should address the reasons for the discrepancy between current data and those from the RCTs.
引用
- Lindgren A, Turner EB, Sillekens T, et al. Outcome After Clipping and Coiling for Aneurysmal Subarachnoid Hemorrhage in Clinical Practice in Europe, USA, and Australia. Neurosurgery. 2019. PMID: 29846713. doi:10.1093/neuros/nyy223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。